SomnoMed (ASX:SOM) Construction In Progress: A$0.0 Mil (As of Dec. 2025)


ASX:SOM SomnoMed Ltd ASX:SOM
50 GF Score
Price A$0.54
GF Value A$0.45
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is SomnoMed Construction In Progress?

SomnoMed ASX:SOM +0.94% 50 Construction In Progress is A$0.0 Mil as of Dec. 2025. GuruFocus rates ASX:SOM with a GF Score™ of 50/100 and a GF Value™ of A$0.45 (Modestly Overvalued). The stock has 3 warning signs investors should review.

SomnoMed Construction In Progress Historical Data

* Premium members only.

The historical data trend for SomnoMed's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SomnoMed Construction In Progress Chart

SomnoMed Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

SomnoMed Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ASX:SOM
50GF Score
SomnoMed Ltd ASX:SOM
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SomnoMed Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of A$0.0 Mil mean?
SomnoMed (ASX:SOM) has a Construction In Progress of A$0.0 Mil as of Dec. 2025. Construction in Progress records the amount of construction work that is not complete. View historical data on SomnoMed and its competitors.
Is SomnoMed's Construction In Progress too high?
SomnoMed's current Construction In Progress is A$0.0 Mil. Overall, SomnoMed has a GF Score™ of 50/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SomnoMed's Construction In Progress compare to ABT and SYK?
SomnoMed's Construction In Progress of A$0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Medical Devices & Instruments company?
A good Construction In Progress depends on the Medical Devices & Instruments industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on SomnoMed and its competitors. SomnoMed's current Construction In Progress is A$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SomnoMed stock overvalued right now?
Based on GuruFocus' analysis, SomnoMed (ASX:SOM) is currently considered Modestly Overvalued. The stock's GF Value™ is A$0.45, compared to a current price of A$0.54 — trading 18.9% above its estimated fair value. The current Construction In Progress is A$0.0 Mil. SomnoMed's overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For SomnoMed (ASX:SOM), the current Construction In Progress is A$0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SomnoMed (ASX:SOM) Overvalued in 2026?

Based on GuruFocus' analysis, SomnoMed stock appears to be overvalued. The current stock price of A$0.54 is trading 18.9% above its estimated GF Value™ of A$0.45. GuruFocus considers SomnoMed to be Modestly Overvalued.

Key valuation signals for ASX:SOM:

  • Construction In Progress: A$0.0 Mil
  • GF Value™: A$0.45 vs. price of A$0.54 (18.9% above fair value)
  • GF Score™: 50/100 with 3 warning signs

No single metric tells the full story. See the ASX:SOM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SomnoMed Business Description

Other Exchanges SOMNF:USARJV:Germany
Address 20 Clarke Street, Level 3, Crows Nest, Sydney, NSW, AUS, 2065
SomnoMed Ltd provides treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. It is engaged in commercializing SomnoDent Mandibular Advancement Splint (MAS) and other oral devices for sleep-related disorders in Australia and overseas. The other products in the company's portfolio include SomMorning Repositioner; SomnoBrux splint, a custom-fit, acrylic splint (dental guard) for upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs cleaning tablets that have been developed to clean oral appliances. Geographically, the company generates maximum revenue from Europe, followed by North America and the Asia Pacific region.
50GF Score

Get the complete analysis for ASX:SOM

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.54
Price
A$0.45
GF Value